2022 Antibody Therapeutic Conference (ATC)
Extended Application of Antibody (draft)
Time: 2022.11.15 TUE
Venue: National Biotechnology Research Park, Nangang.
International Convention Hall (Building C)
Agenda:
Time | Activities | Speaker |
9:00-9:30 | Registration | |
9:30-9:40 | Welcome Remarks |
Chung-Hsiun Wu, Ph.D. 吳忠勳 Chairman, Taiwan Antibody Association President, Development Center for Biotechology |
9:40-9:50 | Moderator |
Tse-Wen Chang, Ph.D. 張子文 President, Immunwork, Inc. |
9:50-10:30 | Bispecific Antibody: Sixty Years of Journey from Concept to Medicine |
Herren Wu, Ph.D. 吳和仁 President, HW Biologics Consulting, LLC Former Senior Vice President, R&D, AstraZeneca |
10:30-10:50 | Break | |
10:50-11:30 |
Medicines from the central molecule of the ‘central dogma’: mRNA drugs and vaccines |
Örn Almarsson, Ph.D. Principal of AfiRx, LLC Former CTO of Lyndra Therapeutics |
11:30-12:00 | Site-specific conjugation of cytotoxic drug bundles for homogeneous ADCs with high DAR of 6, 8, or 10 |
Hsing-Mao Art Chu, Ph.D 朱鑫懋 Vice President of R&D, Immunwork, Inc. |
12:00-13:00 | Lunch | |
13:00-13:10 | 3rd meeting of the 3rd TAA General Assembly |
Chung-hsiun Wu, Ph.D. 吳忠勳 President, DCB/Chairman, TAA Chih-Jung Chang, Ph.D. 張志榮 COO, EirGenix Inc./Secretary General, TAA |
13:10-13:20 | Moderator |
Karen Wen, Ph.D. 溫國蘭 COO, GenomeFrontier Therapeutics Inc. |
13:20-14:00 | Adoptive T Cell Therapy of Cancer: First Principles for Lasting Responses |
Cassian Yee, M.D. 余嘉誠 Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center |
14:00-14:30 |
Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using qCART, the Quantum pBac-based CAR-T system |
Sareina Chiung-Yuan Wu, Ph.D 吳瓊媛 CEO, GenomeFrontier Therapeutics Inc. |
14:30-14:50 | Break | |
14:50-15:00 |
Moderator |
Han-Chung Wu, Ph.D 吳漢忠 Director, BioTReC |
15:00-15:40 |
Development of Universal Vaccine |
Chi-Huey Wong, Ph.D. 翁啟惠 Scripps Family Chair Professor, The Scripps Research Institute President Emeritus and Distinguished Research Fellow, Academia Sinica |
15:40-17:00 |
Panel Discussion: Extended Application of Antibody |
Moderator: Han-Chung Wu, Ph.D 吳漢忠 Panelist: Chung-Hsiun Wu, Ph.D. 吳忠勳 Tse-Wen Chang, Ph.D. 張子文 Karen Wen, Ph.D. 溫國蘭 Lee-Cheng Liu, Ph.D. 劉理成 Lih-jiuan Hsu, MD, Ph.D. 徐麗娟 James Chih-Hsin Yang, MD, Ph.D. 楊志新 Chiun Hsu, MD, Ph.D. 許 駿 Chia-Chi (Josh) Lin, MD, Ph.D. 林家齊 |
17:00-17:10 |
Closing Remarks Election Results Announcement |
Chung-Hsiun Wu, Ph.D. 吳忠勳 President, DCB/Chairman, TAA |